Niki BioSolutions NIKI
NASDAQ NIKI
$1.92 -0.08 (-4.00%)
As of: Oct 22, 2026 · 9:30 AM EDT

Niki BioSolutions (NIKI) Share-based Compensation (2024)

Updated

Niki BioSolutions (NIKI) posted Share-based Compensation of $24,312 for FY2025, down 87.5% from $194,846 in FY2024.

Analysis

Niki BioSolutions (NIKI) Share-based Compensation (2024) Analysis & Trends

Since FY2019, Niki BioSolutions has reported Share-based Compensation for 7 years.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of -56.0% (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Share-based Compensation in data going back to FY2019.
  • Business Quant data shows NIKI's Share-based Compensation at $194,846 in FY2024, $1.27 million in FY2023 (-23.2%), $1.65 million in FY2022 (-2.1%) and $1.68 million in FY2021 (+13.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 458.00 Mn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn 166.00 Mn
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn 231.00 Mn
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn 249.00 Mn
10 Niki BioSolutions 1.05 Mn 806,680.18 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2024 5,841.00
Aug 31, 2024 14,577.00
API Access

Niki BioSolutions Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NIKI&period=max&api_key=YOUR_API_KEY